A multi-pronged approach to raw materials testing can help mitigate the risk of future contamination events.
Catherine Shaffer
Advertisement
Catherine Shaffer is a contributing writer to BioPharm International, [email protected].
Articles by Catherine Shaffer
Manufacturing for originator molecules is restricted by regulations, but drug makers can exploit newer technologies for the manufacture of biosimilars.
Advertisement
Latest Updated Articles
Ensuring the Biological Integrity of Raw MaterialsMay 15th 2017
Advertisement
Advertisement